Phase 3 Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have Hodgkin lymphoma that has come back or stopped responding to ABVD chemotherapy, and whose condition is considered high risk
- People aged 18 to 90 years old
- People whose liver is working well enough, based on specific blood test results being within acceptable ranges
- People whose kidneys are working well enough, based on specific blood test results being within acceptable ranges
- People whose overall physical health and ability to carry out daily activities meets a certain minimum level (confirm with trial site)
- Women who could become pregnant must have a negative pregnancy test before joining
- People who have read and signed the informed consent form agreeing to take part
Who may not be able to join:
- People who choose to withdraw from the study
- People who develop serious side effects rated as severe or life-threatening (grade 3 or 4) according to a specific medical rating scale used in the trial
- People who are lost to follow-up, meaning the trial team is no longer able to contact or monitor them
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Lauro Amador Medina, Hospital regional Alta especialidad Bajío
Phone: 4772697907
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Progression free survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.